Clinical trials
Gliosarcoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
| Completed | 6 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 4 |
| Case Comprehensive Cancer Center | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Erik Mittra | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Massachusetts General Hospital | 1 |
| National Cancer Institute (NCI) | 1 |
| New Approaches to Brain Tumor Therapy Consortium | 1 |
| Northwestern University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gliosarcoma | 18 |
| Glioblastoma | 17 |
| Astrocytoma | 15 |
| Oligodendroglioma | 14 |
| Glioma | 12 |
| Brain Neoplasms | 10 |
| Ependymoma | 10 |
| Central Nervous System Neoplasms | 9 |
| Medulloblastoma | 6 |
| Meningioma | 5 |
Trials
Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.